A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

February 24, 2025

Study Completion Date

February 24, 2025

Conditions
Dry Eye
Interventions
DRUG

Miebo

Miebo applied in both eyes 4 times per day for approximately 30 days before cataract surgery. Following the completion of the standard follow up, approximately 30 days after cataract surgery, subjects will begin a second regimen of Miebo , 4 times per day in both eyes, for approximately 30 days.

Trial Locations (12)

33770

Site 103, Largo

56308

Site 108, Alexandria

57108

Site 107, Sioux Falls

60453

Site 106, Oak Lawn

63131

Site 104, St Louis

78229

Site 110, San Antonio

Site 112, San Antonio

81501

Site 111, Grand Junction

92655

Site 105, Laguna Hills

92954

Site 102, Petaluma

94206

Site 109, Sacramento

03878

Site 101, Somersworth

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT06346340 - A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy | Biotech Hunter | Biotech Hunter